D Hollard

No ORCID on file · 2 papers in corpus · active 1990-1994

Study types

  • article 1
  • review 1
review 1994
·doi:10.1002/1097-0142(19940615)73:12<3073::aid-cncr2820731228>3.0.co;2-#

BACKGROUND: Treatment of myelodysplastic syndromes (MDSs) remains unsatisfactory. A limited number of reports provide contradictory information on whether danazol, a synthetic androgen, may be useful in patients with MDS. METHODS: Between 1…

article 1990

We report the positive effect of danazol on clinical and hematological data in a patient with myelofibrosis and myeloid metaplasia. Severe cytopenia was corrected within 2 months and was maintained for an additional 2-month period. Myeloid …